drugset / Trial / NCT07525375
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to evaluate the effect of 2 different GP metered dose inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma.
Timeline
- Start
- 2026-04-14
- Primary completion
- 2029-05-23
- Completion
- 2029-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrronium | Unknown | — | Inhaled |
| Background | Budesonide and Formoterol Fumarate | Unknown | — | Inhaled |